ABBVIE INC. vs. CAMP4 Therapeutics Corporation Common Stock
ABBVIE INC. (ABBV) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| ABBV | CAMP | |
|---|---|---|
| Market Cap | $459.82 billion | $281.76 million |
| Revenue (TTM) | $64.39 billion | $4.22 million |
| Net Income (TTM) | $6.32 billion | $-107,244,000 |
ABBV leads on 3 of 3 size & scale factors.
Valuation
| ABBV | CAMP | |
|---|---|---|
| P/E Ratio | 72.64 | — |
| Price / Book | -78.09 | -406.58 |
| Price / Sales | 7.14 | 66.83 |
ABBV and CAMP split the valuation factors evenly.
Profitability
| ABBV | CAMP | |
|---|---|---|
| Net Margin | 9.81% | -2543.74% |
| Return on Equity | -107.29% | 15475.32% |
ABBV and CAMP split the profitability factors evenly.
Dividend
| ABBV | CAMP | |
|---|---|---|
| Dividend Yield | 2.69% | — |
| Payout Ratio | 195.48 | — |
ABBV and CAMP split the dividend factors evenly.
Risk & Sentiment
| ABBV | CAMP | |
|---|---|---|
| Short Interest | 0.85% | 2.82% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, CAMP overview, CAMP financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.